Board Meeting
Colgate-Palmolive (India) Board Meeting Oct 22 2026
Colgate-Palmolive (India) Ltd: Board will meet on 2026-10-22 to approve unaudited Q2 and H1 FY2026 financial results and consider declaration of an interim dividend.

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
4
Neutral
8
Bullish
2
Bearish
36
Neutral
8
Bullish
2
Bearish
32
Neutral
0
Bullish
0
Bearish
4
Neutral
8
Bullish
2
Bearish
4
Neutral
8
Bullish
2
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Personal Products
Personal Care
49,504 Cr
Low Risk
36.7
41.1
4.0
31.3
2,329.85
1,716.00
Sales CAGR
Profit CAGR
ROE
ROCE

Colgate-Palmolive (India) Ltd (COLPAL) is currently trading at 1,770.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Colgate-Palmolive (India) Limited is a leading provider of oral care products, offering toothpastes, toothpowder, toothbrushes, and mouthwashes under the 'Colgate' brand, alongside personal care products under 'Palmolive'. The company ended FY 2024-25 with a revenue of Rs. 5,999 crores, marking a 6.3% growth driven by strong performances in toothpaste and toothbrush categories. EBITDA margins stood at 32.6%. An intense focus on premiumization and innovation led to successful launches like the Colgate Visible White Purple and Max Fresh Sensorials, contributing to sustainable volume growth, especially in premium segments. Significant urban-rural disparities exist, with rural areas showing robust growth contrary to urban slowing, especially in the lower 70% income segment. Premium category growth continues to be strong in urban areas. Colgate's strategic initiative 'Oral Health Movement' engaged 4.5 million consumers, leveraging technology for oral health assessments, contributing to a vast database for oral care insights in India.
Over the past 52 weeks, Colgate-Palmolive (India) Ltd has traded between a low of ₹1,716.00 and a high of ₹2,329.85. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Colgate-Palmolive (India) Ltd has a market capitalization of approximately 49,504.11. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Colgate-Palmolive (India) Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 36.73 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 49,504.11 Cr, Colgate-Palmolive (India) Ltd is classified as a Mid Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Colgate-Palmolive (India) Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Colgate-Palmolive (India) Ltd is 36.73. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
The board meeting to consider and approve unaudited Q1 FY27 results is scheduled for July 29, 2026, for the quarter ended June 30, 2026.
Revenue rose 11.8% year-on-year to ₹1,603 crore, compared with ₹1,434 crore in the base quarter.
Net profit was ₹320.62 crore for the quarter ended June 2025 (Q1 FY26), down 12% year-on-year from ₹363.98 crore.
Nomura upgraded the stock from ‘Reduce’ to ‘Buy’ and raised its target to ₹2,500, citing improving volume trends and expectations of better FY27 earnings growth.
Board Meeting
Colgate-Palmolive (India) Ltd: Board will meet on 2026-10-22 to approve unaudited Q2 and H1 FY2026 financial results and consider declaration of an interim dividend.
Regulatory/Compliance Filing
Colgate-Palmolive (India) filed a Confirmation Certificate under Regulation 74(5) from RTA MUFG Intime for the quarter ended 30-09-2026 confirming dematerialisation and listing of securities.
Regulatory/Compliance Filing
Colgate-Palmolive (India) published a newspaper notice under Reg 30 opening a special window (05-Feb-2026 to 04-Feb-2027) to re-lodge physical share transfer requests lodged before 01-Apr-2019; reissued shares will be in demat.